IMIDAZOQUINOLINYL, IMIDAZOPYRIDINYL AND IMIDAZONAPHTHYRIDINYL SULFONAMIDES
申请人:3M Innovative Properties Company
公开号:EP1699788A2
公开(公告)日:2006-09-13
IMIDAZOQUINOLINYL SULFONAMIDES
申请人:Bonk Jason D.
公开号:US20090062272A1
公开(公告)日:2009-03-05
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamide compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
US8735421B2
申请人:——
公开号:US8735421B2
公开(公告)日:2014-05-27
[EN] IMIDAZOQUINOLINYL, IMIDAZOPYRIDINYL, AND IMIDAZONAPHTHYRIDINYL SULFONAMIDES<br/>[FR] SULFONAMIDES D'IMIDAZOQUINOLINYLE, D'IMIDAZOPYRIDINYLE ET D'IMIDAZONAPHTYRIDINYLE